Cargando…
Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France
We enrolled 136 patients with laboratory-confirmed monkeypox during June 4–August 31, 2022, at the University Hospital Institute Méditerranée Infection in Marseille, France. The median patient age was 36 years (interquartile range 31–42 years). Of 136 patients, 125 (92%) were men who have sex with m...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707593/ https://www.ncbi.nlm.nih.gov/pubmed/36241422 http://dx.doi.org/10.3201/eid2812.221440 |
_version_ | 1784840734267932672 |
---|---|
author | Cassir, Nadim Cardona, Florian Tissot-Dupont, Hervé Bruel, Christiane Doudier, Barbara Lahouel, Salima Bendamardji, Karim Boschi, Céline Aherfi, Sarah Edouard, Sophie Lagier, Jean-Christophe Colson, Philippe Gautret, Philippe Fournier, Pierre-Edouard Parola, Philippe Brouqui, Philippe La-Scola, Bernard Million, Matthieu |
author_facet | Cassir, Nadim Cardona, Florian Tissot-Dupont, Hervé Bruel, Christiane Doudier, Barbara Lahouel, Salima Bendamardji, Karim Boschi, Céline Aherfi, Sarah Edouard, Sophie Lagier, Jean-Christophe Colson, Philippe Gautret, Philippe Fournier, Pierre-Edouard Parola, Philippe Brouqui, Philippe La-Scola, Bernard Million, Matthieu |
author_sort | Cassir, Nadim |
collection | PubMed |
description | We enrolled 136 patients with laboratory-confirmed monkeypox during June 4–August 31, 2022, at the University Hospital Institute Méditerranée Infection in Marseille, France. The median patient age was 36 years (interquartile range 31–42 years). Of 136 patients, 125 (92%) were men who have sex with men, 15 (11%) reported previous smallpox vaccinations, and 21 (15.5%) were HIV-positive. The most frequent lesion locations were the genitals (68 patients, 53%), perianal region (65 patients, 49%), and oral/perioral area (22 patients, 17%). Lesion locations largely corresponded with the route of contamination. Most (68%) patients had isolated anal, genital, or oral lesions when they were first seen, including 56 (61%) who had >1 positive site without a visible lesion. Concurrent sexually transmitted infections were diagnosed in 19 (15%) patients, and 7 patients (5%) were asymptomatic. We recommend vaccination campaigns, intensified testing for sexually transmitted infections, and increased contact tracing to control the ongoing monkeypox outbreak. |
format | Online Article Text |
id | pubmed-9707593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-97075932022-12-09 Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France Cassir, Nadim Cardona, Florian Tissot-Dupont, Hervé Bruel, Christiane Doudier, Barbara Lahouel, Salima Bendamardji, Karim Boschi, Céline Aherfi, Sarah Edouard, Sophie Lagier, Jean-Christophe Colson, Philippe Gautret, Philippe Fournier, Pierre-Edouard Parola, Philippe Brouqui, Philippe La-Scola, Bernard Million, Matthieu Emerg Infect Dis Research We enrolled 136 patients with laboratory-confirmed monkeypox during June 4–August 31, 2022, at the University Hospital Institute Méditerranée Infection in Marseille, France. The median patient age was 36 years (interquartile range 31–42 years). Of 136 patients, 125 (92%) were men who have sex with men, 15 (11%) reported previous smallpox vaccinations, and 21 (15.5%) were HIV-positive. The most frequent lesion locations were the genitals (68 patients, 53%), perianal region (65 patients, 49%), and oral/perioral area (22 patients, 17%). Lesion locations largely corresponded with the route of contamination. Most (68%) patients had isolated anal, genital, or oral lesions when they were first seen, including 56 (61%) who had >1 positive site without a visible lesion. Concurrent sexually transmitted infections were diagnosed in 19 (15%) patients, and 7 patients (5%) were asymptomatic. We recommend vaccination campaigns, intensified testing for sexually transmitted infections, and increased contact tracing to control the ongoing monkeypox outbreak. Centers for Disease Control and Prevention 2022-12 /pmc/articles/PMC9707593/ /pubmed/36241422 http://dx.doi.org/10.3201/eid2812.221440 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Cassir, Nadim Cardona, Florian Tissot-Dupont, Hervé Bruel, Christiane Doudier, Barbara Lahouel, Salima Bendamardji, Karim Boschi, Céline Aherfi, Sarah Edouard, Sophie Lagier, Jean-Christophe Colson, Philippe Gautret, Philippe Fournier, Pierre-Edouard Parola, Philippe Brouqui, Philippe La-Scola, Bernard Million, Matthieu Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France |
title | Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France |
title_full | Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France |
title_fullStr | Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France |
title_full_unstemmed | Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France |
title_short | Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France |
title_sort | observational cohort study of evolving epidemiologic, clinical, and virologic features of monkeypox in southern france |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707593/ https://www.ncbi.nlm.nih.gov/pubmed/36241422 http://dx.doi.org/10.3201/eid2812.221440 |
work_keys_str_mv | AT cassirnadim observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT cardonaflorian observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT tissotdupontherve observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT bruelchristiane observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT doudierbarbara observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT lahouelsalima observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT bendamardjikarim observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT boschiceline observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT aherfisarah observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT edouardsophie observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT lagierjeanchristophe observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT colsonphilippe observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT gautretphilippe observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT fournierpierreedouard observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT parolaphilippe observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT brouquiphilippe observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT lascolabernard observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance AT millionmatthieu observationalcohortstudyofevolvingepidemiologicclinicalandvirologicfeaturesofmonkeypoxinsouthernfrance |